Milestones are going to ignite the next move in PPS likely in April. Patent applicatioins in both the EU and US are on the drawing board, and that news alone could attract investors like we haven't seen. Once these are completed in both the US and EU, and Phase I protcol is approved in EU later in April, and in the US probably next quarter some time, PPCH will move out of the shaddows of obscurity onto the world stage. It is difficult to predict exactly what that will mean, but I believe the pps will see a dramatic rise to over .10 in the 3rd quarter, and depending on news it could be much higher. If there is BP interest expressed as Phase I initiates, there could be a very dramatic move that will shock all of us. Risk and reward at this juncture seems highly in favor of reward. Exciting days ahead!
(4)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links